<DOC>
	<DOC>NCT00917696</DOC>
	<brief_summary>This study will evaluate ATP-induced Pain (AIP) and ATP-induced dermal vasodilation (AIDV) as target engagement tools for future development of analgesics.</brief_summary>
	<brief_title>Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Subject is in generally good health Subject is willing to abstain from smoking within 24 hours of each iontophoresis treatment and limit smoking to 5 or less cigarettes per week during the study Subject has a history of dermatitis, psoriasis, or eczema Subject has active asthma and/or hay fever at the time of the screening visit Subject is unable to refrain from use of analgesics within 3 days prior to each treatment period</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>